title: Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice.
abstract: Severe burns induce a state of immunosuppression, and the inflammatory response after burn injury may play a role in this phenomenon. This study examined the effect of the inflammatory response to endotoxin on burn-induced immunosuppression and oxidative stress. An endotoxin-resistant mouse strain (C3H/HeJ) and a normally responding mouse strain (C3H/HeN) were compared. The mice were separated into three groups of five animals for each experimental day: (1) saline, (2) buprenorphine, and (3) buprenorphine and 20% total body surface area burn. All animals were fed ad libitum. The inflammatory response was studied at 1, 4, 7, 10, and 14 days postburn. Proliferation of activated splenocytes in burn mice was significantly lower on days 7, 10, and 14 for the C3H/HeJ strain and on days 4 and 10 for the C3H/HeN strain. Globally, C3H/HeJ presented stronger immune suppression than C3H/HeN. Oxidative stress parameters (liver malonaldehyde, spleen metabolic activity, and thiol concentrations) were higher in endotoxin-resistant mice than in the control strain. Impairment of the inflammatory response was more pronounced and oxidative stress was greater in endotoxin-resistant burn mice than in normal burn controls. Buprenorphine administration was not related to depression of these immune parameters. The inflammatory response following burn injury may be beneficial to the immune system.
authors.affiliation: Centre hospitalier de l'Université de Montréal (CHUM)-Hôtel-Dieu, Centre des grands brûlés, Montréal, PQ, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Jobin
authors.forename: D R
authors.initials: DR
authors.lastname: Garrel
authors.forename: J
authors.initials: J
authors.lastname: Bernier
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use; D000818:Animals; D002047:Buprenorphine / Q000627:therapeutic use; D002056:Burns / Q000188:drug therapy / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D002455:Cell Division; D002478:Cells, Cultured; D004351:Drug Resistance / Q000276:immunology; D004435:Eating; D005260:Female; D016130:Immunophenotyping; D008070:Lipopolysaccharides / Q000276:immunology* / Q000494:pharmacology; D008315:Malondialdehyde / Q000032:analysis; D051379:Mice; D008809:Mice, Inbred C3H; D018384:Oxidative Stress; D013154:Spleen / Q000166:cytology; D013438:Sulfhydryl Compounds / Q000032:analysis; D015430:Weight Gain
chemical_list: D000701:Analgesics, Opioid; D008070:Lipopolysaccharides; D013438:Sulfhydryl Compounds; D002047:Buprenorphine; D008315:Malondialdehyde